Publication date: December 2026 Source: The Lancet Regional Health - Europe, Volume 71 Author(s): Tiago Machado, Giacomo Capone, IJsbrand den Rooijen, Felix Bindt, Marta Marcelino, Jacobus van Wyk, Ana Zanoletty Perez, Laura Pioppo, Rui Santos Ivo, Peter Arlett
Clinical trials on medicinal products in the EU/EEA, 2013–2025: a cross-sectional analysis of CTIS and EudraCT data. // The Lancet Regional Health - Europe. – URL: https://www.sciencedirect.com/science/article/pii/S2666776226002966?dgcid=rss_sd_all
Clinical trials on medicinal products in the EU/EEA, 2013–2025: a cross-sectional analysis of CTIS and EudraCT data. The Lancet Regional Health - Europe. https://www.sciencedirect.com/science/article/pii/S2666776226002966?dgcid=rss_sd_all
“Clinical trials on medicinal products in the EU/EEA, 2013–2025: a cross-sectional analysis of CTIS and EudraCT data.” The Lancet Regional Health - Europe.
@article{article69259,
title = {Clinical trials on medicinal products in the EU/EEA, 2013–2025: a cross-sectional analysis of CTIS and EudraCT data},
journal = {The Lancet Regional Health - Europe},
url = {https://www.sciencedirect.com/science/article/pii/S2666776226002966?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...